CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hugel Inc Company Snapshot
Hugel Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hugel Inc with three other companies in this sector in South Korea: Choong Ang Vaccine Laboratory (2016 sales of 37.90 billion Korean Won [US$35.63 million] ), Medy Tox Inc (133.26 billion Korean Won [US$125.26 million] of which 100% was Biological), and Cell Biotech Co ., Limited. (58.28 billion Korean Won [US$54.78 million] of which 88% was Finished Products).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hugel Inc
  Stock Performance Chart for Hugel Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 592,000
(Figures in Korean Won)
1 Week 6.3%   13 Weeks 23.6%  
4 Weeks 29.9%   52 Weeks 80.5%  
 
Hugel Inc Key Data:
  Ticker: 145020 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 124,189,443,779
(Year Ending Jan 2017).
Employees: 126
  Currency: Korean Won Market Cap: 2,529,714,272,000
  Fiscal Yr Ends: December Shares Outstanding: 4,273,166
  Share Type: Common Closely Held Shares: 2,071,468
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.